 An unblinded, randomized, cross-over design with each patient participating in two 40-hour outpatient admissions: a Experimental involving automated Control to Range CTR and b Control using Continuous Glucose Monitor CGM- augmented insulin pump treatment outside of a hospital based clinical research center. 